Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining -0.44% today. In the last week its performance is 9.28%, and 18.29% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 34.12, so today’s gain of -0.44% is a significant step towards its target price. The GAP today is therefore 0.26%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 86.07 B, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 13.80%.
At the current price of 34.02, it has a dividend yield of 5.58%, and its target price is 34.12. This is with a profit margin of 15.20%, and total debt/equity of 1.34. AstraZeneca PLC (NYSE:AZN) has a P/E of 25.41, as well as a forward P/E of 17.29.
With a current EPS of 1.34, and a forecasted EPS growth for next year at 5.81%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -17.60%. For the next five years EPS growth is projected to be 7.30%.
Performance for the year is 23.46%. Since its IPO date on 5/17/1993, the total performance to date is 28.65%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 3723766, while its average volume is 4369.78. Whilst the total gain today was -0.44%, it did have a day high of -1.93%.
Volatility for this week has been at 1.64%, and 1.12% for the month. The 52-week low for AstraZeneca PLC, AZN has been 37.57%, while the 52-week-high has reached -1.93%.
Looking at its return of investments, which is 15.00%, and its return on assets is 5.40%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 21.40%. With a sales growth of -11.60% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 1.12, and has a current ratio of 0.8 and 0.6 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is 3.48, and the P/S is 3.86, along with a P/B of 6.63. Meanwhile it has a p/cash of 23.52.